ATX 3.33% 14.5¢ amplia therapeutics limited

Ann: ACCENT Trial Recruitment Progress, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,726 Posts.
    lightbulb Created with Sketch. 182
    science is intact and we are getting close to know if the drug enhances chemo
    Given the faster recruitment/ willingness of patients, probability of patients staying on the trial past 28 days is high ... if that happens we will possibly know some early efficacy results

    previously I was told that patients can stay on if they are willing to do so
    That info is not yet released to the market, and I am hoping they will release some info in the next quarterly
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.